Q1 EARNINGS: Integra bearing fruit; currency headaches for PerkinElmer, Teleflex
This article was originally published in Clinica
Executive Summary
Integra LifeSciences had another high-quality quarter in Q1, said Jefferies analyst Raj Denhoy, highlighting strong organic revenue growth and improving profitability. The company’s sales of $233.7m grew 9% year-on-year or 7% on an organic basis, surpassing analyst consensus of $230m.